PCM
AMAG

Price Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Price Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4,300
Closed -$235K – 245
2015
Q1 		$235K Sell
4,300
-26,270
-86% -$1.25M 0.15% 187
2014
Q4 		$1.3M Buy
+30,570
New +$1.1M 1.15% 41

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Price Capital Management's AMAG Position: Q2 2015 in Review

Price Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2015, closing a stake of 4,300 shares — an estimated $235K sold.

Price Capital Management first reported a position in AMAG in Q4 2014 and held it in 2 quarters. The position peaked at $1.3M in Q4 2014. 208 funds tracked by Wall St. Rank hold AMAG as of Q2 2015.

  • Price Capital Management reported no remaining AMAG Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Price Capital Management sold 4,300 AMAG Pharmaceuticals shares in Q2 2015, an estimated $235K.
  • Price Capital Management first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Price Capital Management's AMAG Pharmaceuticals position peaked at $1.3M in Q4 2014.
  • 208 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2015.

Based on Price Capital Management's 13F filing for Q2 2015.